Filing Details
- Accession Number:
- 0001209191-15-010932
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2015-02-09 17:30:39
- Reporting Period:
- 2014-12-31
- Filing Date:
- 2015-02-09
- Accepted Time:
- 2015-02-09 17:30:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1404644 | Aquinox Pharmaceuticals Inc | AQXP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1413821 | B Stephen Shrewsbury | C/O Aquinox Pharmaceuticals, Inc. 450 - 887 Great Northern Way Vancouver A1 V5T 4T5 | Cmo; Senior Vp Clinical Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-02 | 400 | $8.22 | 400 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct |
Billionaire Hedge Funds
